New treatments give HIV reporting added weight. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

New treatments give HIV reporting added weight. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Alert. 1997 Jul;12(7):80-3. Unique Identifier : AIDSLINE MED/97702687

Abstract: The success of early combination therapy has underscored the importance of early detection, but is spurring efforts at both the State and Federal levels to push for mandatory HIV reporting. Protease inhibitors have precipitated the debate over a public health approach to HIV. The Coburn bill proposes mandatory reporting and partner notification, and is endorsed by the American Medical Association and has 100 co-sponsors, but has controversial provisions that make it unacceptable to AIDS activists who fear that name reporting could jeopardize civil rights. The need for information sharing is becoming increasingly important now that HIV treatment is being initiated earlier in the course of the infection.

Keywords: *Disease Notification/LEGISLATION & JURISPRUD *HIV Infections/PREVENTION & CONTROL *Population Surveillance
971030
M97A1296

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .